Intrahepatic cholangiocarcinoma: current perspectives

References

• ShinHROhJKMasuyerEComparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma – focus on East and South-Eastern AsiaAsian Pac J Cancer Prev20101151159116621198257
   PubMedGoogle Scholar
• SingalAKVautheyJNGradyJJStroehleinJRIntra-hepatic cholangiocarcinoma – frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer CenterJ Cancer Res Clin Oncol201113771071107821207060
   PubMedGoogle Scholar
• EverhartJERuhlCEBurden of digestive diseases in the United States Part III: liver, biliary tract, and pancreasGastroenterology200913641134114419245868
   PubMed Web of Science ®Google Scholar
• DeOliveiraMLCunninghamSCCameronJLCholangiocarcinoma: thirty-one-year experience with 564 patients at a single institutionAnn Surg2007245575576217457168
   PubMed Web of Science ®Google Scholar
• KonstantinidisITGroot KoerkampBDoRKUnresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneCancer2016122575876526695839
   PubMed Web of Science ®Google Scholar
• EsnaolaNFMeyerJEKarachristosAMarankiJLCampERDenlingerCSEvaluation and management of intrahepatic and extrahepatic cholangiocarcinomaCancer201612291349136926799932
   PubMed Web of Science ®Google Scholar
• NakeebATranKQBlackMJImproved survival in resected biliary malignanciesSurgery20021324555563 discussion 563–55412407338
   PubMedGoogle Scholar
• EndoIGonenMYoppACIntrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resectionAnn Surg20082481849618580211
   PubMed Web of Science ®Google Scholar
• de JongMCNathanHSotiropoulosGCIntrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessmentJ Clin Oncol201129233140314521730269
   PubMed Web of Science ®Google Scholar
• AminiNEjazASpolveratoGKimYHermanJMPawlikTMTemporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysisJ Surg Oncol2014110216317024676600
   PubMed Web of Science ®Google Scholar
• TysonGLEl-SeragHBRisk factors for cholangiocarcinomaHepatology201154117318421488076
   PubMed Web of Science ®Google Scholar
• KhanSAToledanoMBTaylor-RobinsonSDEpidemiology, risk factors, and pathogenesis of cholangiocarcinomaHPB (Oxford)2008102778218773060
   PubMed Web of Science ®Google Scholar
• BritoAFAbrantesAMEncarnacaoJCTralhãoJGBotelhoMFCholangiocarcinoma: from molecular biology to treatmentMed Oncol2015321124526427701
   PubMedGoogle Scholar
• DodsonRMWeissMJCosgroveDIntrahepatic cholangiocarcinoma: management options and emerging therapiesJ Am Coll Surg20132174736750.e423890842
   PubMed Web of Science ®Google Scholar
• CasperFWSeufertRJAtrial natriuretic peptide (ANP) in preeclampsia-like syndrome in a rat modelExp Clin Endocrinol Diabetes199510352922968536057
   PubMed Web of Science ®Google Scholar
• AndersonCDPinsonCWBerlinJChariRSDiagnosis and treatment of cholangiocarcinomaOncologist2004914357
   PubMed Web of Science ®Google Scholar
• OlnesMJErlichRA review and update on cholangiocarcinomaOncology200466316717915218306
   PubMed Web of Science ®Google Scholar
• NakanumaYSatoYHaradaKSasakiMXuJIkedaHPathological classification of intrahepatic cholangiocarcinoma based on a new conceptWorld J Hepatol201021241942721191517
   PubMedGoogle Scholar
• O’DellMRHuangJLWhitney-MillerCLKras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinomaCancer Res20127261557156722266220
   PubMed Web of Science ®Google Scholar
• FavaGLorenziniIMolecular pathogenesis of cholangiocarcinomaInt J Hepatol2012201263054321994887
   PubMedGoogle Scholar
• JohnsonCHanYHughartNMcCarraJAlpiniGMengFInterleukin-6 and its receptor, key players in hepatobiliary inflammation and cancerTransl Gastrointest Cancer201211587022724089
   PubMedGoogle Scholar
• GoydosJSBrumfieldAMFrezzaEBoothALotzeMTCartySEMarked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical markerAnn Surg199822733984049527063
   PubMedGoogle Scholar
• LeeKHLeeKBKimTYClinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinomaBMC Cancer20151572126475437
   PubMed Web of Science ®Google Scholar
• DengGHuCZhuLDownregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cellsInt J Mol Med201434366166824968753
   PubMedGoogle Scholar
• LazaridisKNGoresGJCholangiocarcinomaGastroenterology200512861655166715887157
   PubMed Web of Science ®Google Scholar
• ChungYEKimMJParkYNVarying appearances of cholangiocarcinoma: radiologic-pathologic correlationRadiographics200929368370019448110
   PubMedGoogle Scholar
• KangYLeeJMKimSHHanJKChoiBIIntrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR imagesRadiology2012264375176022798225
   PubMedGoogle Scholar
• OkabayashiTYamamotoJKosugeTA new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variablesCancer20019292374238311745293
   PubMedGoogle Scholar
• KimSJLeeJMHanJKKimKHLeeJYChoiBIPeripheral mass-forming cholangiocarcinoma in cirrhotic liverAJR Am J Roentgenol200718961428143418029881
   PubMedGoogle Scholar
• MamoneGMarroneGCarusoSIntrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phaseAbdom Imaging20154072313232225962708
   PubMedGoogle Scholar
• LimJHCholangiocarcinoma: morphologic classification according to growth pattern and imaging findingsAJR Am J Roentgenol2003181381982712933488
   PubMed Web of Science ®Google Scholar
• LimJHYiCALimHKLeeWJLeeSJKimSHRadiological spectrum of intraductal papillary tumors of the bile ductsKorean J Radiol200231576311919480
   PubMedGoogle Scholar
• MittelstaedtCAUltrasound of the bile ductsSemin Roentgenol19973231611719253067
   PubMedGoogle Scholar
• ParkHSLeeJMKimSHCT differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasisAJR Am J Roentgenol2006187244545316861550
   PubMedGoogle Scholar
• LimJHParkCKPathology of cholangiocarcinomaAbdom Imaging200429554054715383897
   PubMedGoogle Scholar
• SasakiAAramakiMKawanoKIntrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatmentBr J Surg1998859120612099752860
   PubMedGoogle Scholar
• JarnaginWRWeberSTickooSKCombined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factorsCancer20029472040204611932907
   PubMed Web of Science ®Google Scholar
• MaximinSGaneshanDMShanbhogueAKCurrent update on combined hepatocellular-cholangiocarcinomaEur J Radiol Open20141404826937426
   PubMedGoogle Scholar
• WuPCFangJWLauVKLaiCLLoCKLauJYClassification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implicationsAm J Pathol19961494116711758863666
   PubMed Web of Science ®Google Scholar
• WooHGLeeJHYoonJHIdentification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinomaCancer Res20107083034304120395200
   PubMed Web of Science ®Google Scholar
• EdgeSBByrdDRComptonCCFritzAGGreeneFLTrottiAAJCC Cancer Staging Manual7th edParisSpringer2010
   Google Scholar
• WeberSMRiberoDO’ReillyEMKokudoNMiyazakiMPawlikTMIntrahepatic cholangiocarcinoma: expert consensus statementHPB (Oxford)201517866968026172134
   PubMed Web of Science ®Google Scholar
• WangYLiJXiaYPrognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomyJ Clin Oncol20133191188119523358969
   PubMed Web of Science ®Google Scholar
• DoussotAGroot-KoerkampBWiggersJKOutcomes after resection of intrahepatic cholangiocarcinoma: external validation and comparison of prognostic modelsJ Am Coll Surg2015221245246126206643
   PubMedGoogle Scholar
• RuysATGroot KoerkampBWiggersJKKlümpenHJten KateFJvan GulikTMPrognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysisAnn Surg Oncol201421248750024081803
   PubMed Web of Science ®Google Scholar
• WiggersJKRuysATGroot KoerkampBBeuersUten KateFJvan GulikTMDifferences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysisJ Gastroenterol Hepatol20142981582159424787096
   PubMed Web of Science ®Google Scholar
• BridgewaterJGallePRKhanSAGuidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJ Hepatol20146061268128924681130
   PubMed Web of Science ®Google Scholar
• SiaDHoshidaYVillanuevaAIntegrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesGastroenterology2013144482984023295441
   PubMed Web of Science ®Google Scholar
• IguchiTAishimaSTaketomiAFascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysisHum Pathol200940217418018835624
   PubMed Web of Science ®Google Scholar
• ShafizadehNGrenertJPSahaiVKakarSEpidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladderHum Pathol201041448549220040392
   PubMed Web of Science ®Google Scholar
• HerbergerBBergerWPuhallaHSimultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cellsMol Cancer Ther2009861547155619509244
   PubMedGoogle Scholar
• HigashiMYamadaNYokoyamaSPathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming typePathobiology201279210110622286058
   PubMed Web of Science ®Google Scholar
• ParkSYRohSJKimYNExpression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impactOncol Rep200922364965719639217
   PubMedGoogle Scholar
• YehCNPangSTWuRCChenTWJanYYChenMFPrognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomyOncol Rep2009211495619082442
   PubMed Web of Science ®Google Scholar
• HashimotoNYachidaSOkanoKImmunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomasAnn Surg Oncol200916239540319034576
   PubMedGoogle Scholar
• JarnaginWRKlimstraDSHezelMDifferential cell cycle- regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcomeJ Clin Oncol20062471152116016505435
   PubMedGoogle Scholar
• FiorentinoMAltimariAD’ErricoALow p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinomaClin Cancer Res20017123994399911751492
   PubMedGoogle Scholar
• RazumilavaNGoresGJCholangiocarcinomaLancet201438399352168217924581682
   PubMed Web of Science ®Google Scholar
• BrownKMParmarADGellerDAIntrahepatic cholangiocarcinomaSurg Oncol Clin N Am201423223124624560108
   PubMed Web of Science ®Google Scholar
• Netherlands Comprehensive Cancer OrganisationOncoline: Clinical practice guidelines Available from: http://www.oncoline.nl/Accessed August 10, 2016
   Google Scholar
• VallsCGumaAPuigIIntrahepatic peripheral cholangiocarcinoma: CT evaluationAbdom Imaging200025549049610931983
   PubMedGoogle Scholar
• WeberASchmidRMPrinzCDiagnostic approaches for cholangiocarcinomaWorld J Gastroenterol200814264131413618636656
   PubMedGoogle Scholar
• SutharMPurohitSBhargavVGoyalPRole of MRCP in differentiation of benign and malignant causes of biliary obstructionJ Clin Diagn Res2015911TC08TC12
   PubMedGoogle Scholar
• AndersonCDRiceMHPinsonCWChapmanWCChariRSDelbekeDFluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinomaJ Gastrointest Surg200481909714746840
   PubMedGoogle Scholar
• KimYJYunMLeeWJKimKSLeeJDUsefulness of 18F-FDG PET in intrahepatic cholangiocarcinomaEur J Nucl Med Mol Imaging200330111467147214579085
   PubMedGoogle Scholar
• CorveraCUBlumgartLHAkhurstT18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancerJ Am Coll Surg20082061576518155569
   PubMed Web of Science ®Google Scholar
• WeberSMJarnaginWRKlimstraDDeMatteoRPFongYBlumgartLHIntrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomesJ Am Coll Surg2001193438439111584966
   PubMed Web of Science ®Google Scholar
• GoereDWagholikarGDPessauxPUtility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinomaSurg Endosc200620572172516508808
   PubMed Web of Science ®Google Scholar
• van der GaagNAKloekJJde CastroSMBuschORvan GulikTMGoumaDJPreoperative biliary drainage in patients with obstructive jaundice: history and current statusJ Gastrointest Surg200913481482018726134
   PubMed Web of Science ®Google Scholar
• NimuraYPreoperative biliary drainage before resection for cholangiocarcinoma (Pro)HPB (Oxford)200810213013318773090
   PubMed Web of Science ®Google Scholar
• KawasakiSImamuraHKobayashiANoikeTMiwaSMiyagawaSResults of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemi-hepatic portal vein embolizationAnn Surg20032381849212832969
   PubMed Web of Science ®Google Scholar
• IaconoCRuzzenenteACampagnaroTBortolasiLValdegamberiAGuglielmiARole of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacksAnn Surg2013257219120423013805
   PubMed Web of Science ®Google Scholar
• WiggersJKGroot KoerkampBCieslakKPPostoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnantJ Am Coll Surg20162232321331.e127063572
   PubMed Web of Science ®Google Scholar
• FargesORegimbeauJMFuksDMulticentre European study of preoperative biliary drainage for hilar cholangiocarcinomaBr J Surg2013100227428323124720
   PubMedGoogle Scholar
• van DeldenOMLamérisJSPercutaneous drainage and stenting for palliation of malignant bile duct obstructionEur Radiol200818344845617960388
   PubMed Web of Science ®Google Scholar
• GamanagattiSSinghTSharmaRSrivastavaDNDashNRGargPKUnilobar versus bilobar biliary drainage: effect on quality of life and bilirubin level reductionIndian J Palliat Care2016221506226962281
   PubMedGoogle Scholar
• van LiendenKPvan den EsschertJWde GraafWPortal vein embolization before liver resection: a systematic reviewCardiovasc Intervent Radiol2013361253422806245
   PubMed Web of Science ®Google Scholar
• SpolveratoGVitaleACucchettiACan hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?Cancer2015121223998400626264223
   PubMed Web of Science ®Google Scholar
• RiberoDPinnaADGuglielmiASurgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patientsArch Surg2012147121107111322910846
   PubMedGoogle Scholar
• HyderOHatzarasISotiropoulosGCRecurrence after operative management of intrahepatic cholangiocarcinomaSurgery2013153681181823499016
   PubMed Web of Science ®Google Scholar
• LuoXYuanLWangYGeRSunYWeiGSurvival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort studyJ Gastrointest Surg201418356257224395070
   PubMed Web of Science ®Google Scholar
• SulpiceLRayarMBoucherEPrachtMMeunierBBoudjemaKTreatment of recurrent intrahepatic cholangiocarcinomaBr J Surg201299121711171723132419
   PubMed Web of Science ®Google Scholar
• FargesOFuksDBoleslawskiEInfluence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study groupAnn Surg20112545824829 discussion 83022042474
   PubMed Web of Science ®Google Scholar
• SpolveratoGKimYEjazAConditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patientsJAMA Surg2015150653854525831462
   PubMed Web of Science ®Google Scholar
• SpolveratoGKimYAlexandrescuSIs hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaborationAnn Surg Oncol20152272218222525354576
   PubMed Web of Science ®Google Scholar
• AminiNSpolveratoGKimYPawlikTMTrends in hospital volume and failure to rescue for pancreatic surgeryJ Gastrointest Surg20151991581159225794484
   PubMedGoogle Scholar
• GurusamyKSLiJVaughanJSharmaDDavidsonBRCardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resectionCochrane Database Syst Rev20125CD00733822592720
   PubMedGoogle Scholar
• KimYEjazAGaniFCrystalloid administration among patients undergoing liver surgery: defining patient- and provider-level variationSurgery2016159238939826263833
   PubMedGoogle Scholar
• HartogHIjzermansJNvan GulikTMGroot KoerkampBResection of perihilar cholangiocarcinomaSurg Clin North Am201696224726727017863
   PubMedGoogle Scholar
• AbbasSSandroussiCSystematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinomaHPB (Oxford)201315749250323750491
   PubMed Web of Science ®Google Scholar
• GiulianteFGauzolinoRVelloneMArditoFMurazioMNuzzoGLiver resection for intrahepatic cholangiocarcinomaTumori200591648749216457147
   PubMedGoogle Scholar
• GurusamyKSLiJSharmaDDavidsonBRCardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resectionCochrane Database Syst Rev20094CD00733819821405
   PubMedGoogle Scholar
• SpolveratoGEjazAKimYPatterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-targeted hepatectomy databaseJ Surg Res2015196222122825881789
   PubMedGoogle Scholar
• FongYBrennanMFBrownKHeffernanNBlumgartLHDrainage is unnecessary after elective liver resectionAm J Surg199617111581628554132
   PubMedGoogle Scholar
• ButteJMGrendarJBatheOThe role of peri-hepatic drain placement in liver surgery: a prospective analysisHPB (Oxford)2014161093694225041265
   PubMedGoogle Scholar
• Brooke-SmithMFiguerasJUllahSProspective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre studyHPB (Oxford)2015171465125059275
   PubMedGoogle Scholar
• SapisochinGFernández de SevillaEEcheverriJCharcoRLiver transplantation for cholangiocarcinoma: current status and new insightsWorld J Hepatol20157222396240326464755
   PubMedGoogle Scholar
• DeOliveiraMLLiver transplantation for cholangiocarcinoma: current best practiceCurr Opin Organ Transplant201419324525224811436
   PubMedGoogle Scholar
• RoblesRFiguerasJTurrionVSSpanish experience in liver transplantation for hilar and peripheral cholangiocarcinomaAnn Surg2004239226527114745336
   PubMed Web of Science ®Google Scholar
• CasavillaFAMarshJWIwatsukiSHepatic resection and transplantation for peripheral cholangiocarcinomaJ Am Coll Surg199718554294369358085
   PubMed Web of Science ®Google Scholar
• JanYYYehCNYehTSChenTCPrognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial HospitalWorld J Gastroenterol200511121779178415793863
   PubMedGoogle Scholar
• MeyerCGPennIJamesLLiver transplantation for cholangiocarcinoma: results in 207 patientsTransplantation20006981633163710836374
   PubMed Web of Science ®Google Scholar
• GhaliPMarottaPJYoshidaEMLiver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experienceLiver Transpl200511111412141616237695
   PubMed Web of Science ®Google Scholar
• WeimannAVarnholtHSchlittHJRetrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinomaBr J Surg20008791182118710971425
   PubMedGoogle Scholar
• GroeschlRTPappasSGChristiansKKAre we justified in excluding combined hepatocellular-cholangiocarcinoma from transplantation?J Clin Oncol201230Suppl 425622184397
   PubMedGoogle Scholar
• RizviSGoresGJPathogenesis, diagnosis, and management of cholangiocarcinomaGastroenterology201314561215122924140396
   PubMed Web of Science ®Google Scholar
• BuettnerSGroot KoerkampBEjazAThe effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients – a multi-institutional analysisJ Surg Oncol2016
   Google Scholar
• ValleJWasanHPalmerDHABC-02 Trial InvestigatorsCisplatin plus gemcitabine versus gemcitabine for biliary tract cancerN Engl J Med2010362141273128120375404
   PubMed Web of Science ®Google Scholar
• HorganAMAmirEWalterTKnoxJJAdjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysisJ Clin Oncol201230161934194022529261
   PubMed Web of Science ®Google Scholar
• ValleJWFuruseJJitlalMCisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsAnn Oncol201425239139824351397
   PubMed Web of Science ®Google Scholar
• GoenkaMKGoenkaUPalliation: hilar cholangiocarcinomaWorld J Hepatol20146855956925232449
   PubMedGoogle Scholar
• TaylorMCMcLeodRSLangerBBiliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysisLiver Transpl20006330230810827230
   PubMed Web of Science ®Google Scholar
• SmithACDowsettJFRussellRCHatfieldARCottonPBRandomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstructionLancet19943448938165516607996958
   PubMed Web of Science ®Google Scholar
• AndersenJRSørensenSMKruseARokkjaerMMatzenPRandomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundiceGut1989308113211352475392
   PubMed Web of Science ®Google Scholar
• SeidenstickerRRickeJSeidenstickerMIntegration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinomaBest Pract Res Clin Gastroenterol201529231933225966431
   PubMed Web of Science ®Google Scholar
• BreedisCYoungGThe blood supply of neoplasms in the liverAm J Pathol195430596997713197542
   PubMed Web of Science ®Google Scholar
• LlovetJMRealMIMontanaXArterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialLancet200235993191734173912049862
   PubMed Web of Science ®Google Scholar
• McAuliffeJCQadanMD’AngelicaMIHepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancerJ Gastrointest Oncol20156669970826697204
   PubMedGoogle Scholar
• KuhlmannJBEuringerWSpangenbergHCTreatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapyEur J Gastroenterol Hepatol201224443744322261548
   PubMed Web of Science ®Google Scholar
• SchiffmanSCMetzgerTDubelGPrecision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survivalAnn Surg Oncol201118243143820862554
   PubMedGoogle Scholar
• SeidenstickerRDeneckeTKrausPMatched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastasesCardiovasc Intervent Radiol20123551066107321800231
   PubMed Web of Science ®Google Scholar
• SangroBCarpaneseLCianniREuropean Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY)Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluationHepatology201154386887821618574
   PubMed Web of Science ®Google Scholar
• CamachoJCKokabiNXingMPrajapatiHJEl-RayesBKimHSModified response evaluation criteria in solid tumors and European Association for the Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolizationJ Vasc Interv Radiol201425225626524461131
   PubMedGoogle Scholar
• MouliSMemonKBakerTYttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysisJ Vasc Interv Radiol20132481227123423602420
   PubMed Web of Science ®Google Scholar
• RafiSPiduruSMEl-RayesBYttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety studyCardiovasc Intervent Radiol201336244044822956045
   PubMed Web of Science ®Google Scholar
• HoffmannRTPaprottkaPMSchönATransarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survivalCardiovasc Intervent Radiol201235110511621431970
   PubMedGoogle Scholar
• SaxenaABesterLChuaTCChuFCMorrisDLYttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment optionAnn Surg Oncol201017248449119876691
   PubMedGoogle Scholar
• IbrahimSMMulcahyMFLewandowskiRJTreatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot studyCancer200811382119212818759346
   PubMed Web of Science ®Google Scholar
• HyderOMarquesHPulitanoCA nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experienceJAMA Surg2014149543243824599477
   PubMed Web of Science ®Google Scholar
• KimYEjazASpolveratoGConditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the US Gastric Cancer CollaborativeAnn Surg Oncol201522255756425287440
   PubMed Web of Science ®Google Scholar
• NathanHde JongMCPulitanoCConditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patientsJ Am Coll Surg2010210575576476476620421045
   PubMedGoogle Scholar
• Groot KoerkampBFongYOutcomes in biliary malignancyJ Surg Oncol2014110558559125250887
   PubMed Web of Science ®Google Scholar
• MerlaALiuKGRajdevLTargeted therapy in biliary tract cancersCurr Treat Options Oncol201516104826266637
   PubMed Web of Science ®Google Scholar
• BlechaczBKomutaMRoskamsTGoresGJClinical diagnosis and staging of cholangiocarcinomaNat Rev Gastroenterol Hepatol20118951252221808282
   PubMed Web of Science ®Google Scholar